{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:30:35Z","timestamp":1749065435122},"reference-count":40,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.humimm.2013.09.010","type":"journal-article","created":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T20:06:36Z","timestamp":1379448396000},"page":"47-58","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Early post-transplant immune monitoring can predict long-term kidney graft survival: Soluble CD30 levels, anti-HLA antibodies and IgA-anti-Fab autoantibodies"],"prefix":"10.1016","volume":"75","author":[{"given":"Mohammad Ali","family":"Amirzargar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliakbar","family":"Amirzargar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Basiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Hajilooi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghodratollah","family":"Roshanaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamreza","family":"Rajabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Mohammadiazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghasem","family":"Solgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.humimm.2013.09.010_b0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MOT.0b013e32834ee402","article-title":"Immunologic monitoring in transplantation revisited","volume":"17","author":"Cravedi","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.humimm.2013.09.010_b0010","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1038\/ki.2010.425","article-title":"Immune monitoring and biomarkers to predict chronic allograft dysfunction","volume":"119","author":"Mannon","year":"2010","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"10.1016\/j.humimm.2013.09.010_b0015","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1600-6143.2006.01691.x","article-title":"Post-transplant HLA class II antibodies and high soluble CD30 levels are independently associated with poor kidney graft survival","volume":"7","author":"Langan","year":"2007","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.humimm.2013.09.010_b0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.ajkd.2012.01.028","article-title":"Immune monitoring of kidney allografts","volume":"60","author":"Ho","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.humimm.2013.09.010_b0025","first-page":"219","article-title":"HLA antibodies and soluble CD30 are associated with poor renal graft outcome: updated results of a single-center cross-sectional study","author":"Langan","year":"2006","journal-title":"Clin Transpl"},{"key":"10.1016\/j.humimm.2013.09.010_b0030","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.humimm.2007.05.004","article-title":"Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30are at high risk for graft loss","volume":"68","author":"Rodr\u00edguez","year":"2007","journal-title":"Hum Immunol"},{"issue":"2\u20133","key":"10.1016\/j.humimm.2013.09.010_b0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.trim.2011.12.002","article-title":"Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA","volume":"26","author":"Solgi","year":"2012","journal-title":"Transpl Immunol"},{"issue":"7","key":"10.1016\/j.humimm.2013.09.010_b0040","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.transproceed.2009.07.053","article-title":"TH1\/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion","volume":"41","author":"Solgi","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.humimm.2013.09.010_b0045","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1097\/00007890-200204270-00014","article-title":"Kidney graft failure and presensitization against HLA class I and class II antigens","volume":"73","author":"S\u00fcsal","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2013.09.010_b0050","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1097\/01.ASN.0000014256.75920.5B","article-title":"Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30","volume":"13","author":"S\u00fcsal","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.humimm.2013.09.010_b0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.trim.2005.03.014","article-title":"Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection","volume":"14","author":"Slavcev","year":"2005","journal-title":"Transplant Immunol"},{"key":"10.1016\/j.humimm.2013.09.010_b0060","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/01.TP.0000152660.56055.53","article-title":"Evaluation of pretransplant immunologic status in kidney-transplant recipients by panel reactive antibody and soluble CD30 determinations","volume":"79","author":"Cinti","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2013.09.010_b0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00007890-200201150-00002","article-title":"Soluble CD30 as a predictor of kidney graft outcome","volume":"73","author":"Pelzl","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2013.09.010_b0070","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1111\/j.1600-6143.2005.01016.x","article-title":"Serial 10year follow-up of HLA and MICA antibody production prior to kidney graft failure","volume":"5","author":"Mizutani","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.humimm.2013.09.010_b0075","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1600-6143.2006.01721.x","article-title":"The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients","volume":"7","author":"Mizutani","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.humimm.2013.09.010_b0080","first-page":"255","article-title":"Detection of HLA and MICA antibodies before kidney graft failure","volume":"7","author":"Mizutani","year":"2006","journal-title":"Clin Transpl"},{"key":"10.1016\/j.humimm.2013.09.010_b0085","first-page":"291","article-title":"Retrospective antibody analysis of thirty patients with kidney graft failure","volume":"7","author":"Kinukawa","year":"2006","journal-title":"Clin Transpl"},{"key":"10.1016\/j.humimm.2013.09.010_b0090","first-page":"305","article-title":"Longitudinal testing of seventy-six renal allograft patients for HLA antibodies: maastricht experience","volume":"7","author":"van den Berg-Loonen","year":"2006","journal-title":"Clin Transpl"},{"key":"10.1016\/j.humimm.2013.09.010_b0095","first-page":"1337","article-title":"The collaborative transplant study. Graft-protective role of high pretransplantation IgA-anti-Fab autoantibodies: confirmatory evidence obtained in more than 4000 kidney transplants","volume":"69","author":"S\u00fcsal","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2013.09.010_b0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00007890-199901270-00022","article-title":"IgA class antibodies and flow cytometric cross-matching in renal transplantation","volume":"67","author":"Doran","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2013.09.010_b0105","doi-asserted-by":"crossref","first-page":"S586","DOI":"10.1111\/j.1432-2277.1994.tb01450.x","article-title":"Pretransplant serum IgA concentration and IgA-anti-Fab autoantibody activity as prognostic indicators of kidney graft survival","volume":"7","author":"S\u00fcsal","year":"1994","journal-title":"Transplant Int"},{"key":"10.1016\/j.humimm.2013.09.010_b0110","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0041-1345(96)00551-9","article-title":"Presensitization and HLA match influence the predictive power of pretransplant serum IgA and IgA-anti-Fab autoantibodies in kidney graft recipients","volume":"29","author":"S\u00fcsal","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.humimm.2013.09.010_b0115","first-page":"1072","article-title":"Excellent kidney graft survival in patients with high pretransplant serum IgA concentrations and IgA-anti-Fab autoantibody activity","volume":"27","author":"S\u00fcsal","year":"1995","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.humimm.2013.09.010_b0120","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.trim.2011.02.003","article-title":"Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft","volume":"25","author":"Pavlova","year":"2011","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.humimm.2013.09.010_b0125","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/01.TP.0000044702.18327.66","article-title":"Evaluation of post-transplantationation soluble CD30 for diagnosis of acute renal allograft rejection","volume":"75","author":"Pelzl","year":"2003","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.humimm.2013.09.010_b0130","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jlb.57.5.726","article-title":"CD30 and type 2 T helper (Th2) responses","volume":"57","author":"Romagnani","year":"1995","journal-title":"J Leukoc Biol"},{"issue":"4","key":"10.1016\/j.humimm.2013.09.010_b0135","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00062752-200307000-00003","article-title":"Expression and a role of CD30 in regulation of T-cell activity","volume":"10","author":"Tarkowski","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.humimm.2013.09.010_b0140","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1111\/j.1600-6143.2005.00966.x","article-title":"High pretransplant soluble CD30 levels are predictive of the grade of rejection","volume":"5","author":"Rajakariar","year":"2005","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.humimm.2013.09.010_b0145","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/00007890-199805150-00016","article-title":"CD30 expression identifies a functional alloreactive human T-lymphocyte subset","volume":"65","author":"Martinez","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2013.09.010_b0150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0966-3274(03)00014-5","article-title":"CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1\/TH2 response","volume":"12","author":"Pellegrini","year":"2003","journal-title":"Transpl Immunol"},{"issue":"6","key":"10.1016\/j.humimm.2013.09.010_b0155","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrneph.2012.81","article-title":"The impact of donor-specific anti-HLA antibodies on late kidney allograft failure","volume":"8","author":"Loupy","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.humimm.2013.09.010_b0160","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1600-6143.2006.01644.x","article-title":"4year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival","volume":"7","author":"Terasaki","year":"2007","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.humimm.2013.09.010_b0165","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/TP.0b013e3181b11b72","article-title":"HLA-specific antibodies developed in the first year post-transplant are predictive of chronic rejection and renal graft loss","volume":"88","author":"Lee","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2013.09.010_b0170","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.humimm.2004.05.010","article-title":"Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I","volume":"65","author":"S\u00fcsal","year":"2004","journal-title":"Hum Immunol"},{"issue":"4","key":"10.1016\/j.humimm.2013.09.010_b0175","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1681\/ASN.2012070663","article-title":"The clinical impact of humoral immunity in pediatric renal transplantation","volume":"24","author":"Chaudhuri","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.humimm.2013.09.010_b0180","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/01.tp.0000174338.97313.5a","article-title":"Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2year prospective trial","volume":"80","author":"Terasaki","year":"2005","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.humimm.2013.09.010_b0185","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1432-2277.2011.01312.x","article-title":"Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules","volume":"24","author":"Ntokou","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.humimm.2013.09.010_b0190","first-page":"171","article-title":"Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a 4year follow-up","author":"Lachmann","year":"2006","journal-title":"Clin Transpl"},{"issue":"6","key":"10.1016\/j.humimm.2013.09.010_b0195","first-page":"201","article-title":"Anti-HLA class II antibodies and chronic allograft nephropathy","author":"Gerbase-DeLima","year":"2006","journal-title":"Clin Transpl"},{"issue":"7","key":"10.1016\/j.humimm.2013.09.010_b0200","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/S0041-1345(98)00896-3","article-title":"Pretransplant serum IgA concentration and IgA-anti-Fab autoantibody activity in living donor renal transplant recipients: a pilot study","volume":"30","author":"Kim","year":"1998","journal-title":"Transplant Proc"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885913005314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885913005314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T05:01:44Z","timestamp":1563944504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885913005314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0198885913005314"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2013.09.010","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early post-transplant immune monitoring can predict long-term kidney graft survival: Soluble CD30 levels, anti-HLA antibodies and IgA-anti-Fab autoantibodies","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2013.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}